Across the market, Cowen & Co. analysts see undervalued stocks. Cigna Corp. (CI) offers opportunity stemming from the margin potential of biosimilars, one reason why the stock is Cowen analyst Gary Taylor’s top pick for the year. Costco Wholesale Corp. (COST) makes the cut because it has low prices, a history of managing inventory in an “agile” manner, and a setup that looks favorable in the current economic backdrop, now that customers across the income spectrum are looking for good deals. Read More...
Across the market, Cowen & Co. analysts see undervalued stocks. Cigna Corp. (CI) offers opportunity stemming from the margin potential of biosimilars, one reason why the stock is Cowen analyst Gary Taylor’s top pick for the year. Costco Wholesale Corp. (COST) makes the cut because it has low prices, a history of managing inventory in an “agile” manner, and a setup that looks favorable in the current economic backdrop, now that customers across the income spectrum are looking for good deals.
Add Comment